National Cervical Cancer Screening in Thailand
- PMID: 33507675
- PMCID: PMC8184188
- DOI: 10.31557/APJCP.2021.22.1.25
National Cervical Cancer Screening in Thailand
Abstract
Background: Cervical cancer is an important public health problem in Thailand. It was the most common cancer in Thai women with the incidence rate of 23.4 per 100,000 women in 1990.
Objective: The aim of this study was to share the experiences and summary the outcome of cervical cancer screening program in Thailand.
Methods: The Ministry of Public Health in cooperation with the National Health Security Office, launched the National Cervical Cancer Screening Program, covering 76 provinces nationwide under Universal Coverage Scheme in 2005. The screening method are Pap smear and Visual Inspection with Acetic acid (VIA) for women aged 30-60 and 35-45 respectively with a 5-year screening interval. Detecting cervical pre-cancerous lesions will follow by day care treatment such as cryotherapy, Loop Electrosurgical Excision Procedure, etc. Results: The first phase (2005-2009), was carried out on 3,124,855 women, the coverage reached 77.5%. For the second phase (2010-2014), 7,637,226 women were screened, reaching 53.9% coverage of target women. However, we have few data of follow up examination after abnormal screening. Therefore, we conducted new system to get more follow up data in 2019. Under the coordination of many related partners, 10,762,081 women have been screened during 2005-2014. The incidence rate declined to 11.7 per 100,000 women which is ranked as the third most common in women in 2014.
Conclusion: This article briefly reviews the challenge of implementing an efficient cervical cancer screening in Thailand. In 2020, HPV testing has been introduced as a primary screening test for all Thai women attending public health sector instead of conventional Pap test.
Keywords: Cervical cancer; Population-based organized screening; Thailand.
Figures


Similar articles
-
Success of a cervical cancer screening program: trends in incidence in songkhla, southern Thailand, 1989-2010, and prediction of future incidences to 2030.Asian Pac J Cancer Prev. 2014;15(22):10003-8. doi: 10.7314/apjcp.2014.15.22.10003. Asian Pac J Cancer Prev. 2014. PMID: 25520060
-
Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study.BMC Public Health. 2016 Aug 17;16(1):806. doi: 10.1186/s12889-016-3530-y. BMC Public Health. 2016. PMID: 27535359 Free PMC article.
-
Effect of the national screening program on malignancy status of cervical cancer in Northern Thailand.Int J Public Health. 2018 Apr;63(3):377-385. doi: 10.1007/s00038-018-1077-7. Epub 2018 Jan 23. Int J Public Health. 2018. PMID: 29362857
-
VIA and cryotherapy: doing what's best.J Med Assoc Thai. 2006 Aug;89(8):1333-9. J Med Assoc Thai. 2006. PMID: 17048450 Review.
-
Histopathological outcomes of women with abnormal cervical cytology: a review of literature in Thailand.Asian Pac J Cancer Prev. 2014;15(16):6489-94. doi: 10.7314/apjcp.2014.15.16.6489. Asian Pac J Cancer Prev. 2014. PMID: 25169475 Review.
Cited by
-
Spontaneous Regression of Cervical Low-Grade Squamous Intraepithelial Lesions in the Northern Thai Population: Impact of Human Immunodeficiency Virus Infection on Regression Rates and Predictors.J Clin Med. 2025 Mar 4;14(5):1726. doi: 10.3390/jcm14051726. J Clin Med. 2025. PMID: 40095809 Free PMC article.
-
Knowledge regarding human papillomavirus and cervical cancer prevention among medical students from Chulalongkorn University in Thailand.BMC Womens Health. 2024 Feb 19;24(1):129. doi: 10.1186/s12905-024-02933-3. BMC Womens Health. 2024. PMID: 38373946 Free PMC article.
-
Analysis of precancerous lesion-related microRNAs for early diagnosis of cervical cancer in the Thai population.Sci Rep. 2025 Jan 2;15(1):142. doi: 10.1038/s41598-024-84080-1. Sci Rep. 2025. PMID: 39747449 Free PMC article.
-
Cervical cancer in Thailand: 2023 update.Obstet Gynecol Sci. 2024 May;67(3):261-269. doi: 10.5468/ogs.23277. Epub 2024 Mar 25. Obstet Gynecol Sci. 2024. PMID: 38528826 Free PMC article.
-
Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting.J Gynecol Oncol. 2024 Nov;35(6):e85. doi: 10.3802/jgo.2024.35.e85. Epub 2024 Apr 18. J Gynecol Oncol. 2024. PMID: 38670561 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials